Clinical Trial Update: Botulinum Toxin to Treat Restless Legs Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 trials evaluated botulinum toxin for restless legs syndrome; the study is completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Restless Legs Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-04-26